The global coagulation analyzers market size was valued at USD 5.1 billion in 2021 and is expected to grow at a CAGR of 10.6% over the forecast period.
A coagulation analyzer could provide diagnostic prevention against blood clots that can potentially induce a heart attack. To test coagulation pathway velocity as well as thrombolin and thromboplastin levels in as little as a few minutes, a coagulation analyzer can be used. A coagulation analyzer is designed specifically to test a large number of patients, allowing up to 600 patient tests per well to be stored. Micro coagulation systems use bar-coded cuvettes to speed up assay completion and proper identification, avoiding the need to encode each test sample separately. With the sensitive nature of patient health information, to ensure safe and secure use, advanced coagulation analyzers come with built-in quality control and security lockout protocols.
Request a Sample@ https://www.qyresearchmedical.com/sample/119148
Coagulation Analyzers Market: Dynamics
Rising awareness about early diagnosis to drive market growth
Blood coagulation analysis is a complex science and coagulation analyzers play a crucial role in the process of determining a blood clot. Most coagulation analyzers are heading toward accuracy, ease of use, and timely results thus boosting coagulation analyzers market revenue. Advancement in technology for better bioinformatics and integrated software across multiple platforms will also add impetus to market growth. Additionally, market players such as Roche, Siemens, Sysmex, Abott and others have been launching new products that are each more advanced than the last, thus creating considerable revenue growth opportunities. For instance, at the China International Import Expo in 2021, Roche showcased its cobas t 711 coagulation analyzer. Equipped with the intelligent Walk Away Reagent Management, the analyzer is designed to be capable of fully automated and scheduled reagent reconstitution — enabling continuous operation. The product also helped to improve the company’s coagulation pipeline in China.
Hereditary disorders as well as vitamin K deficiency and heart disease can lead to clotting of blood. The rising awareness regarding blood clots and the fact that they are preventable with early diagnosis are factors that are driving the coagulation analysers market. According to the CDC, more than 100,000 people die in the U.S. each year due to blood clots. People with pulmonary embolism often die without warning. Such factors are also driving the growth of coagulation analyzers market.
Lack of developed healthcare infrastructure to restrain market
Lack of awareness about timely blood clot detection and shortage of skilled coagulation analyzers operators restrain market growth over the coming years. A large portion of the population in developing nations are yet uneducated about the need of regular check-up. People in many under-privileged nations do not have access to adequate healthcare. Such factors can pose considerable challenges for the growth of the coagulation analyzers market during the forecast period.
Analyzers retained a dominant share of the total revenue in 2021 and are expected to grow at a substantial CAGR over the forecast period. Factors augmenting this growth are expected to be better healthcare infrastructure, higher healthcare spending and increasing incidence of lifestyle-related disorders such as diabetes, obesity, and cardiovascular disorders. Emphasis on providing quality care to patients will also propel segment growth.
Optical technology is projected to hold the highest revenue share over the forecast period. This growth is expected owing to combination of immunological, chromogenic with a photo-optical technique which has resulted in the development of high performing, multipurpose optical hemostasis analyzers.
Test Type Outlook
In terms of test type, the D-dimer segment was estimated to account for the largest share. Studies have shown that elevated levels of D-dimer and t-PA antigens are associated with the risk of coronary heart disease (CHD). As deaths due to cardiovascular disease are expected to increase, it is expected that the need for methods used for D-Dimer analysis will increase, as this will help to better understand CHD. The World Health Organisation, for example, has said that cardiovascular diseases are the number one cause of deaths worldwide, killing an estimated 17.9 million people per year. It is therefore expected that increasing mortality associated with cardiovascular disorders would increase the demand for D-Dimer research.
On the basis of end users, the market is segmented as hospitals, diagnostic centres, research institute and others. Rapid expansion in hospitals and primary healthcare centres will render the hospital segment to be the leading revenue generation segment. Additionally, favorable government initiatives to improve healthcare delivery are expected to help future growth. The availability of advanced equipment is another vital driver for the growth.
North America dominated the coagulation analyzers market in 2021, a trend that is expected to continue over the coming years. A combination of factors have brought about the market dominance of the region. Some factors such as a rising geriatric population, sedentary lifestyle, obesity epidemic, unhealthy diet etc. has predisposed a large section of the North American population towards developing blood clotting disorders. Moreover, through greater public and private initiative, such as “Stop The Clot, Spread The Word”, awareness about early diagnosis of blood clots has been spread which has created better opportunities for coagulation analyzers market. Favourable healthcare resources and easy access to advanced healthcare solutions will also augment market growth in the region. Additionally the presence of leading market players such as Roche, Siemens, Sysmex, Abott and others would also add considerable impetus to market growth. Such players make substantial investments in R&D and are bringing new products to the market on a regular basis driving innovation and revenue growth.
The Asia Pacific coagulation analyzers market is expected to witness a lucrative growth rate owing to adequate hospitals, health centres, and clinics. With economic growth in countries with massive populations such as India and China, and better access to healthcare, more people are paying closer attention to their health thus creating growth opportunities for the industry.
Some of the key industry players include Siemens, Abott, Alere, Helena laboratories, Roche, Instrumentation Laboratory, Stago, Sysmex and Thermofisher.
Segments Covered in the Report
This report forecasts revenue growth and provides an analysis of the industry trends in each of the sub-segments from 2022 to 2030. For the purpose of this study, Reports and Data has segmented the global coagulation analyzers market on the basis of product, technology, test type, end-use, and region:
Product Outlook (Revenue, USD Million, 2022 – 2030)
- Clinical Laboratory Analyzers
- Point of Care Analyzers
Technology Outlook (Revenue, USD Million, 2022 – 2030)
Test Type Outlook (Revenue, USD Million, 2022 – 2030)
End-Use Outlook (Revenue, USD Million, 2022 – 2030)
- Research Institutes
- Diagnostic Centres
Regional Outlook (Revenue, USD Million, 2022 – 2030)
- North America
- The U.S.
- The U.K.
- Asia Pacific
- Latin America
- South Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119148/1500
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: